Yayınlar & Eserler

Makaleler 49
Tümü (49)
SCI-E, SSCI, AHCI (47)
SCI-E, SSCI, AHCI, ESCI (47)
Scopus (48)
TRDizin (3)
Diğer Yayınlar (1)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 13

2. MOLNUPIRAVIR: A NEW ANTIVIRAL DRUG FOR COVID-19 TREATMENT

2. INTERNATIONAL MARMARA SCIENTIFIC RESEARCH AND INNOVATION CONGRESS, İstanbul, Türkiye, 19 Nisan 2022, ss.63, (Özet Bildiri)

5. Design and Synthesis of Novel 8-Aryl Substituted9-Cyclopentyl Purine Derivatives as PotentialCytotoxic Agents

The 20th International Research Conference, Paris, Fransa, 27 - 28 Ağustos 2018, cilt.20, ss.2081-2083, (Tam Metin Bildiri)

6. NEW PURINE AND PYRIMIDINE NUCLEOSIDE ANALOGS: SYNTHESISAND CYTOTOXIC ACTIVITY ON SELECTED HUMAN CANCER CELL LINES

12th International Symposium onPharmaceutical Sciences (ISOPS-12), Ankara, Türkiye, 26 - 29 Haziran 2018, ss.91-92, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

9. Synthesis and In Vitro Anticancer Activity of Novel 6,8,9-Trisubstituted Purine Analogs

3 rd International Multidisciplinary Symposium on Drug Research and Development - DRD 2017, Erzurum, Türkiye, 5 - 07 Ekim 2017, (Özet Bildiri)

10. Synthesis and Cytotoxic Activities of New Nucleobase andNucleoside analogs

VEK 3rd International Convention ofPharmaceuticals and Pharmacies, İstanbul, Türkiye, 26 - 29 Nisan 2017, (Özet Bildiri)

11. A QSAR Study On Cytotoxic Activities Of Novel 6,8,9 -Trisubstituted Purine Derivatives

21st European Symposium on Quantitative Structure-Activity Relationship, Verona, İtalya, 4 - 08 Eylül 2016, (Tam Metin Bildiri)
Metrikler

Yayın

67

Yayın (WoS)

47

Yayın (Scopus)

48

Atıf (WoS)

708

H-İndeks (WoS)

17

Proje

7

Tez Danışmanlığı

5

Açık Erişim

7
BM Sürdürülebilir Kalkınma Amaçları